388 related articles for article (PubMed ID: 34769423)
1. Neurodegenerative Disorders: Spotlight on Sphingolipids.
Mandik F; Vos M
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769423
[TBL] [Abstract][Full Text] [Related]
2. Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy.
Tringali C; Giussani P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887154
[TBL] [Abstract][Full Text] [Related]
3. Role of Ceramides and Sphingolipids in Parkinson's Disease.
Vos M; Klein C; Hicks AA
J Mol Biol; 2023 Jun; 435(12):168000. PubMed ID: 36764358
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids in mitochondria.
Hernández-Corbacho MJ; Salama MF; Canals D; Senkal CE; Obeid LM
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jan; 1862(1):56-68. PubMed ID: 27697478
[TBL] [Abstract][Full Text] [Related]
5. Sphingoid bases and their involvement in neurodegenerative diseases.
Goins L; Spassieva S
Adv Biol Regul; 2018 Dec; 70():65-73. PubMed ID: 30377075
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Bouscary A; Quessada C; René F; Spedding M; Turner BJ; Henriques A; Ngo ST; Loeffler JP
Semin Cell Dev Biol; 2021 Apr; 112():82-91. PubMed ID: 33160824
[TBL] [Abstract][Full Text] [Related]
8. Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.
Custodia A; Romaus-Sanjurjo D; Aramburu-Núñez M; Álvarez-Rafael D; Vázquez-Vázquez L; Camino-Castiñeiras J; Leira Y; Pías-Peleteiro JM; Aldrey JM; Sobrino T; Ouro A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897658
[TBL] [Abstract][Full Text] [Related]
9. Ceramide induced mitophagy and tumor suppression.
Dany M; Ogretmen B
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt B):2834-45. PubMed ID: 25634657
[TBL] [Abstract][Full Text] [Related]
10. Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.
Custodia A; Aramburu-Núñez M; Correa-Paz C; Posado-Fernández A; Gómez-Larrauri A; Castillo J; Gómez-Muñoz A; Sobrino T; Ouro A
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202192
[TBL] [Abstract][Full Text] [Related]
11. Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases.
Pujol-Lereis LM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330872
[TBL] [Abstract][Full Text] [Related]
12. Ceramide function in the brain: when a slight tilt is enough.
Mencarelli C; Martinez-Martinez P
Cell Mol Life Sci; 2013 Jan; 70(2):181-203. PubMed ID: 22729185
[TBL] [Abstract][Full Text] [Related]
13. Defective lipid metabolism in neurodegeneration with brain iron accumulation (NBIA) syndromes: not only a matter of iron.
Colombelli C; Aoun M; Tiranti V
J Inherit Metab Dis; 2015 Jan; 38(1):123-36. PubMed ID: 25300979
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria and neurodegenerative diseases: Special issue of BMB Reports in 2020.
Chung KC
BMB Rep; 2020 Jan; 53(1):1-2. PubMed ID: 31865963
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases.
Li X; Huang L; Lan J; Feng X; Li P; Wu L; Peng Y
Pharmacol Res; 2021 Jan; 163():105240. PubMed ID: 33053441
[TBL] [Abstract][Full Text] [Related]
16. Role of mitophagy in mitochondrial quality control: Mechanisms and potential implications for neurodegenerative diseases.
Wang XL; Feng ST; Wang ZZ; Chen NH; Zhang Y
Pharmacol Res; 2021 Mar; 165():105433. PubMed ID: 33454337
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
Roszczyc-Owsiejczuk K; Zabielski P
Front Endocrinol (Lausanne); 2021; 12():635175. PubMed ID: 33815291
[TBL] [Abstract][Full Text] [Related]
18. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
19. Genetic defects in the sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease.
Allende ML; Zhu H; Kono M; Hoachlander-Hobby LE; Huso VL; Proia RL
Cell Signal; 2021 Feb; 78():109879. PubMed ID: 33296739
[TBL] [Abstract][Full Text] [Related]
20. Phytoceramide and sphingoid bases derived from brewer's yeast Saccharomyces pastorianus activate peroxisome proliferator-activated receptors.
Murakami I; Wakasa Y; Yamashita S; Kurihara T; Zama K; Kobayashi N; Mizutani Y; Mitsutake S; Shigyo T; Igarashi Y
Lipids Health Dis; 2011 Aug; 10():150. PubMed ID: 21861924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
